日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Inconsistent medication recommendations for immune-mediated inflammatory diseases across pregnancy, lactation, and paternal preconception: a guideline-based review

妊娠期、哺乳期和父亲备孕期间免疫介导炎症性疾病的用药建议不一致:一项基于指南的综述

Van den Broeck, Elise; Lenie, Sien; Ferrante, Marc; De Langhe, Ellen; Neerinckx, Barbara; Hillary, Tom; Van Calsteren, Kristel; Smits, Anne; Sillis, Laure; Julsgaard, Mette; Foulon, Veerle; Ceulemans, Michael

Hydrogen sulfide rescues IFNγ/TNFα-induced intestinal epithelial barrier dysfunction by enhancing oxidative phosphorylation

硫化氢通过增强氧化磷酸化作用来挽救IFNγ/TNFα诱导的肠上皮屏障功能障碍。

de Oliveira, Janaíne Prata; van Sligtenhorst, Matthias; Akkaya, Cansu; Verbiest, Astrid; Alves, Victoria Francelino; Wallays, Marie; van der Merwe, Schalk; Ferrante, Marc; Vanuytsel, Tim; Wallace, John L; Muscará, Marcelo N; Costa, Soraia K P; Denadai-Souza, Alexandre

Cooking methods affect advanced glycation end products and lipid profiles: A randomized cross-over study in healthy subjects.

烹饪方法影响晚期糖基化终产物和血脂谱:一项针对健康受试者的随机交叉研究

Wellens Judith, Vissers Eva, Dumoulin Anaïs, Hoekx Sien, Vanderstappen Julie, Verbeke Joke, Vangoitsenhoven Roman, Derrien Muriel, Verstockt Bram, Ferrante Marc, Matthys Christophe, Raes Jeroen, Verbeke Kristin, Vermeire Séverine, Sabino João

Risankizumab efficacy and safety based on prior inadequate response or intolerance to advanced therapy: post hoc analysis of the INSPIRE and COMMAND phase 3 studies

基于既往对高级疗法反应不足或不耐受的Risankizumab疗效和安全性:INSPIRE和COMMAND 3期研究的事后分析

Panaccione, Remo; Louis, Edouard; Colombel, Jean-Frederic; D'Haens, Geert; Peyrin-Biroulet, Laurent; Dubinsky, Marla; Takeuchi, Ken; Rubin, David T; Kalabic, Jasmina; Chien, Karen B; Chen, Su; Cheng, Ling; Zhang, Yafei; Duan, W Rachel; Vladea, Ramona; Hecht, Patrick M; Morisset, Pierre; Schreiber, Stefan; Ferrante, Marc

Achievement of Endoscopic Remission After Induction Reduces Hospitalization Burden in Crohn's Disease: Findings From a Pooled Post Hoc Analysis of Risankizumab and Upadacitinib Phase III Trials

诱导治疗后达到内镜下缓解可减轻克罗恩病患者的住院负担:Risankizumab 和 Upadacitinib III 期试验的汇总事后分析结果

Panaccione, Remo; Ma, Christopher; Jairath, Vipul; Dignass, Axel; Joshi, Namita; Clark, Ryan; Griffith, Jenny; Kligys, Kristina; Semwal, Monika; Smith, Zachary; Mitchell, Dominic; Nunag, Dominic; Ferrante, Marc

Risankizumab Is Associated With Normalization of Biomarkers in Patients With Crohn's Disease: Results From the Phase 3 ADVANCE, MOTIVATE, and FORTIFY Studies

Risankizumab 与克罗恩病患者生物标志物正常化相关:来自 3 期 ADVANCE、MOTIVATE 和 FORTIFY 研究的结果

Atreya, Raja; Ferrante, Marc; Panaccione, Remo; Feagan, Brian; Shchukina, Oksana; Jairath, Vipul; Rieder, Florian; Hisamatsu, Tadakazu; Siegmund, Britta; Kligys, Kristina; Song, Alexandra; Zambrano, Javier; Mallick, Madhuja; Zhang, Yafei; Armuzzi, Alessandro; D'Haens, Geert

FFAR4 drives stem cell fate toward lipid- and iron-storing enterocytes protecting human enteroids from ferroptosis

FFAR4 驱动干细胞分化为储存脂质和铁的肠细胞,从而保护人类肠类器官免受铁死亡的影响

Farhadipour, Mona; Leng, Hui; Thijs, Theo; Dubois, Antoine; Deleus, Ellen; Van der Schueren, Bart; Lannoo, Matthias; Ceulemans, Laurens J; Ferrante, Marc; Depoortere, Inge

Evolution of Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials: A Clinical Trial Databank Analysis

炎症性肠病临床试验入组标准的演变:一项临床试验数据库分析

Outtier, An; Janssens, Rosanne; Barbier, Liese; Sabino, João; Verstockt, Bram; Vermeire, Séverine; Huys, Isabelle; Ferrante, Marc

Assessment of PredictSURE IBD Assay in a Multinational Cohort of Patients With Inflammatory Bowel Disease

在多国炎症性肠病患者队列中评估 PredictSURE IBD 检测

Alsoud, Dahham; Noor, Nurulamin M; Chen, Lea Ann; Abadom, Vivian; Anderson, Simon H C; Ardolli, Lediona; Axelrad, Jordan; Bossuyt, Peter; Croitoru, Kenneth; Damas, Oriana M; Deng, Lily; Deepak, Parakkal; Negro, Juan De La Revilla; de Silva, Shanika; Ferrante, Marc; Hills, Karen; Irving, Peter M; Lindsay, James O; Lukin, Dana J; Lyons, Paul A; McKinney, Eoin F; Oliva-Hemker, Maria; Oneto, Caterina; Patel, Roohi; Parkes, Miles; Pouillon, Lieven; Sabino, João; Saubermann, Lawrence J; Sauk, Jenny S; Sheibani, Sarah; Smith, Kenneth G C; Sultan, Keith S; Tham, Tony C; Verstockt, Sare; Vrabie, Raluca; Weidner, Melissa; Yu, Huimin; Verstockt, Bram; Lee, James C; Vermeire, Séverine

Dietary Carrageenan Amplifies the Inflammatory Profile, but not Permeability, of Intestinal Epithelial Cells from Patients With Crohn's Disease.

膳食角叉菜胶会增强克罗恩病患者肠道上皮细胞的炎症反应,但不会增加其通透性

Vissers Eva, Wellens Judith, Giorio Lorenzo, Zadora Ward, Verstockt Bram, Ferrante Marc, Vermeire Séverine, Matthys Christophe, Arnauts Kaline, Sabino João